Schweitzer-Mauduit International, Inc. — Q1 2015 Form 10-Q
Period: Three months ended March 31, 2015. The filing is for Schweitzer-Mauduit International, Inc. (SWM); the request metadata names Mativ Holdings, Inc., so the issuer identity should be verified. SWM produced specialty papers, reconstituted tobacco products and filtration materials.
Financial results
| Metric | Q1 2015 | Q1 2014 |
|---|---|---|
| Net sales | $188.0 million | $204.7 million |
| Gross profit / margin | $51.4 million / 27.3% | $57.6 million / 28.1% |
| Operating profit / margin | $22.5 million / 12.0% | $33.1 million / 16.2% |
| Net income | $18.8 million | $23.2 million |
| Diluted EPS | $0.61 | $0.75 |
| Cash from operations | $11.2 million | $18.3 million |
| Capital spending | $5.2 million | $8.1 million |
Revenue declined 8.2%, primarily reflecting $17.8 million of unfavorable currency translation, mainly from the weaker euro, and lower LIP product prices. Acquisitions contributed $7.1 million of Filtration sales. Gross profit fell 10.8%; management cited currency, unfavorable Paper product mix and pricing, and costs from restarting a rebuilt French production line. The effective tax rate decreased to 24.0% from 30.2%, mainly due to geographic earnings mix and prior-year realignment actions.
Segments and material changes
- Paper: Sales of $108.6 million, down 15.7%; operating profit of $16.1 million, down 28.4%. Lower LIP volume, prices and mix, currency, and restart inefficiencies weighed on results; improved utilization and lower manufacturing costs partly offset the decline.
- Reconstituted Tobacco: Sales of $38.9 million, down 12.0%; operating profit of $10.9 million, down 32.7%. Currency and higher French restructuring costs were key factors.
- Filtration: Sales of $40.5 million, up 27.8%; operating profit of $2.6 million versus $0.4 million. Acquisitions and core growth helped; results also benefited from lower acquisition inventory step-up amortization.
Restructuring and impairment expense increased to $4.0 million from $0.1 million, including $3.1 million of French severance accruals and a $0.7 million loss on equipment disposal. Comprehensive loss was $40.6 million, versus comprehensive income of $26.6 million, largely reflecting a $48.7 million foreign-currency translation loss and $7.0 million of derivative-related other comprehensive loss.
Cash, debt and liquidity
- Cash was $267.3 million at March 31, down from $290.3 million at year-end; $263.5 million was held by foreign subsidiaries.
- Total debt was $442.8 million, including $439.6 million long-term debt. The company reported $70.7 million of availability under its $500 million credit facility and $32.2 million under other overdraft facilities and lines of credit.
- The credit facility covenants require net debt/EBITDA of no more than 3.00 and interest coverage of at least 3.50; SWM reported compliance. Total debt to capital was 50.5%, compared with 47.4% at year-end.
- Operating working capital used $19.9 million of cash, largely from increased receivables. Dividends paid were $11.6 million; net borrowings provided $12.5 million. The company repurchased $2.9 million of shares, primarily for employee tax withholding obligations.
Outlook, risks and contingencies
SWM expected 2015 capital spending of approximately $30–$35 million. It described continued tobacco-market volume pressure and LIP pricing competition, while identifying Filtration growth, diversification, potential acquisitions and cost-reduction initiatives as opportunities. It gave no specific earnings or revenue guidance. Management expected tobacco paper and reconstituted tobacco volumes to face industry attrition; timing of new LIP regulations was uncertain.
Brazilian subsidiary SWM-B faced tax assessments involving raw-material ICMS taxes of approximately $32 million (about $14 million subject to an indemnification) and electricity-related assessments totaling approximately $16 million. The company reported no liability for these matters, believed it would ultimately prevail, and cautioned that outcomes were uncertain. Environmental and other legal proceedings were also disclosed; management did not expect other proceedings to have a material adverse effect, but could not assure outcomes. European patent opposition decisions were under appeal.
Investor verification priorities
- Confirm the issuer and corporate lineage: this 2015 filing identifies Schweitzer-Mauduit International, Inc., not Mativ Holdings, Inc.
- Assess whether the sales, margin and cash-flow declines—especially in Paper and Reconstituted Tobacco—persisted beyond Q1.
- Track foreign-exchange effects, the large translation loss, and the proportion of cash held overseas and its availability for domestic needs.
- Review credit-facility headroom and covenant compliance alongside debt levels and planned capital spending and shareholder distributions.
- Monitor the Brazil tax cases, related indemnification, patent appeals, and restructuring costs and expected benefits.